In human WM793 and WM35 melanoma cell lines, leptin treatment activated the MAPK pathway and enhanced cell proliferation, suggesting that leptin may act as a melanoma growth factor, and may contribute to the uncontrolled proliferation of these cells [220]. Here, LEP is linked to melanoma.